Related Experiment Videos
Adhesion interactions involved in eosinophil migration through vascular endothelium
A J Wardlaw1, G M Walsh, F A Symon
1Department of Respiratory Medicine, Leicester University Medical School, Glenfield Hospital, UK.
Annals of the New York Academy of Sciences
|October 31, 1996
Summary
Eosinophils migrate to allergic inflammation sites via unique molecular interactions. Targeting these eosinophil adhesion mechanisms offers a promising therapeutic strategy for allergic diseases.
Area of Science:
- Immunology
- Molecular Biology
- Allergic Inflammation Research
Background:
- Eosinophil migration is key in allergic inflammation.
- Distinct adhesion molecule expression differentiates eosinophils from neutrophils.
Purpose of the Study:
- To elucidate the molecular mechanisms of eosinophil migration in allergic inflammation.
- To identify potential therapeutic targets for allergic diseases.
Main Methods:
- Comparative analysis of eosinophil and neutrophil adhesion molecule expression (e.g., alpha 4 beta 1, alpha 4 beta 7, alpha 6 beta 1, PSGL-1).
- Review of current evidence on mediators and receptors involved in eosinophil migration.
Main Results:
- Eosinophils express unique adhesion receptors (alpha 4 beta 1, alpha 4 beta 7, alpha 6 beta 1) not found on neutrophils.
- Structural differences in eosinophil PSGL-1 enhance binding to P-selectin.
- Eosinophils persist in tissues due to local cytokines, contributing to accumulation.
Conclusions:
- Understanding eosinophil-specific molecular pathways is crucial for treating allergic diseases.
- Targeting leucocyte migration presents a viable therapeutic approach.
- Animal models show promise for developing novel anti-allergic drugs.